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Abstract
Background: Salmonella enterica serovar Gallinarum (S. Gallinarum) is the causative agent of fowl
typhoid, a severe systemic disease of chickens that results in high mortality amongst infected flocks.
Due to its virulence, the immune response to S. Gallinarum is poorly characterised. In this study
we have utilised infection by the live attenuated S. Gallinarum 9R vaccine strain in inbred chickens
to characterise humoral, cellular and cytokine responses to systemic salmonellosis.
Results: Infection with 9R results in a mild systemic infection. Bacterial clearance at three weeks
post infection coincides with increases in circulating anti-Salmonella antibodies, increased T cell
proliferation to Salmonella challenge and increased expression of interferon gamma. These
responses peak at four weeks post infection, then decline. Only modest increases of expression of
the pro-inflammatory cytokine interleukin-1β were detected early in the infection.
Conclusion: Infection of chickens with the 9R vaccine strain induces a mild form of systemic
salmonellosis. This induces both cellular and humoral immune responses, which peak soon after
bacterial clearance. Unlike enteric-associated Salmonella infections the immune response is not
prolonged, reflecting the absence of persistence of Salmonella in the gastrointestinal tract. The
findings here indicate that the use of the S. Gallinarum 9R vaccine strain is an effective model to
study immunity to systemic salmonellosis in the chicken and may be employed in further studies to
determine which components of the immune response are needed for protection.
Background
Salmonella enterica serovar Gallinarum (S. Gallinarum) is
the causative agent of fowl typhoid, a severe systemic dis-
ease of chickens and other galliforme birds [1]. S. Galli-
narum is a non-motile Gram negative rod and along with
the closely related Salmonella enterica serovar Pullorum is
host-specific for poultry, but rarely, if ever, presents a risk
of zoonotic transmission to man. Infection in chickens
may occur at all ages and is typified by severe hepat-
osplenomegaly accompanied by characteristic liver
'bronzing', anaemia and septicaemia [1]. S. Gallinarum is
primarily associated with the mononuclear phagocyte
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liver and spleen [2,3]. It is only found in the gastrointesti-
nal tract early in the infection, usually through faecal-oral
transmission, and in the end stage of fowl typhoid where
bacteria are shed into the intestines leading to substantial
haemorrhaging of the intestinal wall [3]. Infection leads
to high rates of morbidity and mortality with a recent
study describing a mortality rate in excess of 60% in exper-
imentally infected outbred chickens [4]. Although control
programmes including vaccination have largely control-
led the disease in Europe and North America, it remains
of high economic importance to developing poultry
industries in Asia and South America.
The high mortality and morbidity rates associated with S.
Gallinarum make effective study of immunity to infection
difficult to achieve. Although studies in inbred genetically
resistant and susceptible chickens have demonstrated the
role of the innate immune system to some extent [3], the
role of the adaptive immune response and in particular
cellular responses has not been described other than a few
serological studies [1,2,5]. In order to further characterise
the immune response to S. Gallinarum, we utilised an
infection model with the live attenuated fowl typhoid vac-
cine 9R. The 9R vaccine strain developed in the 1950s, has
a 'semi-rough' lipopolysaccharide structure, but the
nature of its attenuation is not known [6,7]. Although
highly attenuated compared to its parental strain S. Galli-
narum 9, the 9R vaccine strain still results in systemic dis-
ease with pathology in the liver and spleen, and bacterial
persistence for several weeks at these sites [5]. Therefore
although the vaccine strain does not cause significant
mortality, it causes a mild form of systemic salmonellosis.
This allows more detailed study of the immune response
to be undertaken without using high numbers of animals
needed to determine immune responses associated with
clearance due to high mortality rates.
In this study we have determined both humoral and cel-
lular immune responses to systemic salmonellosis in an
inbred chicken line, and investigate expression of two key
cytokines. Line 72 is derived from White Leghorn Chick-
ens and is moderately susceptible to systemic salmonello-
sis [3]. Previous studies have determined both cellular and
humoral responses to Salmonella enterica serovar Typh-
imurium in the chicken [8,9]. Although S. Typhimurium
is mainly associated with the gastrointestinal tract in
chickens, it causes a transient primary systemic infection.
Control of this systemic infection appears to be depend-
ent on cell-mediated immunity as clearance of bacteria
from the spleen and liver coincides with the height of T-
cell proliferative activity and expression of the T helper
1(Th1)-type cytokine interferon-γ (IFN-γ) [8,9]. Infection
with S. Typhimurium also results in specific IgG, IgM and
IgA antibody responses [8], as does vaccination with
killed Salmonella vaccines [10]. Infection with either Sal-
monella serovar Typhimurium or serovar Enteritidis leads
to prolonged high titres of specific antibody, probably as
a consequence of the prolonged persistence of these sero-
vars in the gastrointestinal tract, a phenomenon that is not
found with S. Gallinarum [9,11-13] Whilst it is clear spe-
cific antibody protects against secondary systemic infec-
tion [10], its role in clearance of primary infection is less
clear. Following bursectomy, depletion of the Bursa of
Fabricius the primary lymphoid organ associated with B
lymphocyte development in the chicken, [14,15], con-
flicting results have been found on the role of antibody in
Salmonella clearance. Therefore the role of antibody is not
yet clearly defined in primary avian Salmonella infection.
In this study we have initiated investigation of immunity
to systemic infection with S. Gallinarum. We have deter-
mined both the specific anti-S. Gallinarum antibody (IgG
and IgM) response, the cellular response and expression
of the key cytokines IFN-γ and Interleukin-1β (IL-1β) fol-
lowing oral infection of inbred chickens with S. Galli-
narum 9R.
Results
The S. Gallinarum 9R vaccine strain causes a low level 
systemic infection
Following infection S. Gallinarum 9R was detected in the
spleen and liver at one and two weeks post infection
(Table 1), though no bacteria were detected by three
Table 1: Counts of S. Gallinarum 9R vaccine strain from tissues following oral inoculation of three-week old Line 72 chickens (±SEM)
Tissue Weeks post infection
1 2 3
Mean count Log10 cfu/g Number positive Mean count Log10 cfu/g Number positive Mean count Log10 cfu/g Number positive
Liver 1.84 ± 0.37 5/5 1.43 ± 0.29 5/5 <1 0/5
Spleen 1.39 ± 0.57 4/5 < 1 3/5* <1 0/5
*detected only after enrichment in selenite brothPage 2 of 6
(page number not for citation purposes)
BMC Veterinary Research 2005, 1:2 http://www.biomedcentral.com/1746-6148/1/2weeks post infection or at any subsequent time point. At
both one and two weeks post infection inflammatory
signs including mild to moderate hepatosplenomegaly
were detected in infected birds. This level of pathology is
consistent with previous studies of the 9R strain [5].
Cellular and humoral responses to experimental infection 
with 9R
IgM antibody responses were detected at one week post
infection, and subsequently decreased (Figure 1a),
whereas IgG responses reached a peak three weeks post
infection and subsequently declined (Figure 1b). Cellular
responses followed a similar pattern to IgG production
with significantly higher levels of T-cell proliferation (P <
0.05) to Salmonella antigen in the infected over control
groups found at three-to-four weeks post infection (Figure
2). These findings indicate that oral infection with 9R elic-
its both humoral and cellular immune responses that
coincide with clearance of the bacterium from the liver
and spleen.
Cytokine expression following S. Gallinarum 9R infection
Expression of the Th1-type cytokine IFN-γ followed a sim-
ilar pattern to that of T-cell proliferation with infected
birds showing increased expression over the controls at
three weeks (P = 0.03) and four weeks (P < 0.01) post
infection with up to eight-fold increases in expression
found (Figure 3). The increase is consistent with T-lym-
phocyte activation, particularly Th1 responses. Only mod-
est increases of expression of the pro-inflammatory
cytokine IL-1β were found following infection, though
significantly greater in infected birds at two weeks post
infection (P = 0.02). This increase corresponds to presence
of bacteria in the spleen and mild hepatosplenomegaly in
the infected group. Previous studies have suggested that
presence of high bacterial numbers in the spleen induces
high expression levels of IL-1β [9]. However in this study
relatively limited inflammation was found and it seems
likely that 9R induces only a limited pro-inflammatory
response.
Discussion
The data presented here indicate that systemic Salmonella
infection of the chicken induces both cellular and
humoral responses in the chicken. Both responses peak at
three to four weeks post infection, a point that coincides
with bacterial clearance. Previous studies of immune
responses in avian salmonellosis have concentrated on
virulent or attenuated strains of S. Typhimurium and S.
Enteritidis [9,16-19]. The responses found in these studies
also demonstrated both humoral and cellular responses
Antibody responses to S. Gallinarum 9RFigure 1
Antibody responses to S. Gallinarum 9R. Serum anti-
body responses to S. Gallinarum lysate antigen in S. Galli-
narum 9R infected and control Line 72 chickens infected 
orally at three weeks of age as determined by ELISA (±SEM). 
(A) IgM response (serum diluted 1:50) and (B) IgG response 
(serum diluted 1:200)
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Antigen-specific T lymphocyte proliferation to Sal-
monella. Antigen-specific proliferation of splenic lym-
phocytes from Line 72 chickens infected with S. Gallinarum 
9R or infected controls (±SEM). Proliferation was deter-
mined by the uptake of tritiated thymidine measured 48 h 
after culture of cells with soluble S. Gallinarum antigen. Dif-
ferences between control and infected groups were analysed 
by ANOVA indicating significantly increased proliferation in 
infected over control birds at 3 and 4 weeks post infection (P 
< 0.05)Page 3 of 6
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in contrast to this study, these infections elicit responses
that remain considerably higher than in this study, where
responses declined rapidly after four weeks post infection.
Both S. Typhimurium and S. Enteritidis may persist in the
gastrointestinal tract for many weeks, whereas S. Galli-
narum infection generally results either in the mortality of
susceptible birds or bacterial clearance in resistant birds
within three to four weeks of initial infection, although
occasionally persistent infection occurs [3,20]. It seems
that bacterial persistence in the gastrointestinal tract
maintains a more prolonged immune response. In addi-
tion persistent, low-level, systemic infection of chickens
by Salmonella enterica serovar Pullorum leads to pro-
longed high titre antibody responses and T lymphocyte
proliferation [21].
Although the duration of the primary immune response is
shorter in S. Gallinarum infection, as with the early stages
of S. Typhimurium infection in the chicken, clearance
from the spleen and liver coincides with increased T lym-
phocyte proliferation and expression of IFN-γ [9]. Com-
parative infection studies of Salmonella-resistant naked
neck chicken breed and commercial layers have also
shown correlation between the cellular immune response
and protection against fowl typhoid [22]. In many ways
the biology of S. Gallinarum infection is more akin to S.
Typhimurium infection of the mouse than the chicken. In
common with S. Gallinarum in the chicken, murine infec-
tion with S. Typhimurium results in a severe systemic
'typhoid-like' infection. The development of the murine
immune response to S. Typhimurium has been well char-
acterised and has recently been reviewed [23]. In the early
stages of both murine and avian systemic salmonellosis,
bacterial numbers are initially controlled through the
innate immune system, and in particular through the gen-
eration of reactive oxygen intermediates [3,23]. In the
mouse initiation of the adaptive immunity relies on the
action of a number of cytokines including IFN-γ, Inter-
leukin-12 (IL-12), Interluekin-18 (IL-18) and tumour
necrosis factor-α. Production of IL-12 and IL-18, primarily
by macrophages leads to expression of IFN-γ by natural
killer cells and T lymphocytes, which in turn leads to
increased macrophage activation. These, primarily Th1,
cytokine responses lead to the development of CD4+ T-cell
responses that lead to clearance of Salmonella from the tis-
sues. The response to S. Galllinarum 9R mirrors this, with
an increase in IFN-γ expression correlating to increased T-
cell proliferation and clearance of the vaccine strain from
the tissues. Antibody responses, initially IgM followed by
IgG are produced to 9R in a classical primary response.
These also correlate to the clearance of Salmonella. The rel-
ative roles of humoral and cellular immunity to clearance
are not yet known, though as S. Gallinarum are believed
to survive and multiply within macrophages [2-4], it
would appear to be more likely that Th1-mediated cellular
responses are more important in clearance. Further func-
tional studies will be used to determine the relative roles
of cellular and humoral responses in protection.
The infection model used in this study is a useful tool in
studying the immune response to S. Gallinarum, but
without the high mortality or morbidity rates found with
virulent strains, even in genetically resistant birds. Similar
attenuated vaccines strains have been used extensively in
the S. Typhimurium murine model [23] and also to
characterise the immune responses to Salmonella infection
in cattle [24]. The data presented here indicates that an
immune response consistent with that seen in other
Expression of IFN-γ and IL1-β following infection with S. Gallinarum 9RFigure 3
Expression of IFN-γ and IL1-β following infection with 
S. Gallinarum 9R. Expression of the cytokines IFN-γ (A) 
and IL1-β (B) in the spleen of Line 72 chickens infected with 
S. Gallinarum 9R (±SEM). Expression was determined by 
quantitative reverse-transcription real-time PCR. Data are 
displayed as the mean fold-change in expression in infected 
birds (n = 5) in comparison to uninfected controls (n = 5) at 
the same time point. Differences between control and 
infected groups were analysed by ANOVA indicating signifi-
cantly increased expression of IFN-γ in infected over control 
birds at 3 and 4 weeks post infection (P < 0.05).
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lowing oral infection with the 9R vaccine strain. This rep-
resents a valuable model to study immunity to fowl
typhoid in the chicken. The studies presented here indi-
cate that infection generates both humoral and a Th1-
mediated cellular response. Further studies with this
model will allow the determination of which components
of the response are protective, aiding future rational avian
Salmonella vaccine design.
Conclusion
The S. Gallinarum 9R vaccine strain is a suitable model to
study the immune response to systemic salmonellosis in
the chicken. Infection with 9R induces both antibody and
Th1-type T cell responses that are associated with bacterial
clearance.
Methods
Experimental animals
Specific pathogen-free (SPF) Line 72 inbred White Leg-
horn chickens were obtained form the Poultry Production
Unit, Institute for Animal Health, Compton, UK. Birds
were reared on wire cages initially at an ambient tempera-
ture of 30°C then at 21°C from three weeks old. Birds
were given ad libitum access to water and a vegetable pro-
tein based diet (SDS, Witham, Essex, UK). All experimen-
tal work involving animals was performed under the
conditions of a Home Office project licence and of the
local ethics committee meeting the requirements of UK
legislation.
Bacterial strains
The S. Gallinarum 9R vaccine strain [6] was cultured in
Luria Bertani (LB) broth (Difco, Becton-Dickinson
Labware, Cowley, Oxford, UK) at 37°C in an orbital
shaking incubator at 150 rpm from stocks held at -70°C
in LB broth supplemented with 30% glycerol.
Production of Salmonella lysate antigen
A soluble protein antigen lysate preparation was prepared
from S. Gallinarum 9, the virulent strain from which the
9R vaccine was produced, as previously described [9]. The
antigen preparation was subsequently used for ELISA and
T-cell proliferation assays
Experimental infection with the 9R vaccine strain
Fifty 3 week-old Line 72 chickens were divided into two
groups of equal size and housed separately as described
above. Prior to infection five birds from each group were
bled from the wing vein to obtain serum. The birds of one
group were then infected orally with 108 CFU of the S.
Gallinarum 9R vaccine strain in a volume of 0.3 ml of LB
broth. The second group remained uninfected as controls.
At 1, 2, 3, 4 and 6 weeks post infection, five birds from
each group were killed for post mortem analysis. At each
time point samples of spleen and liver were taken asepti-
cally for bacteriological analysis. A section of splenic tis-
sue was taken into RPMI1640 containing 100 U/ml
penicillin, 1 µg/ml streptomycin and 5% bovine serum to
isolate splenocytes for T-cell proliferation assays. A small
sample of splenic tissue was also obtained for isolation of
RNA using RNAlater (Qiagen, Crawley, UK) to protect
against any degradation. Birds were also bled by cardiac
puncture to obtain serum. For bacteriological analysis
samples were homogenised in sterile phosphate buffered
saline (PBS) using Griffith's tube homogenisers, then seri-
ally diluted in PBS and plated onto Brilliant Green Agar
(Difco, Becton-Dickinson Labware). Plates were then
incubated at 37°C for 24 h, then the bacterial count deter-
mined. Samples were also enriched by adding an equal
volume of double strength selenite broth, followed by
overnight incubation at 37°C. Enriched samples were
plated onto Brilliant Green Agar and incubated as
described above. Growth was then recorded as Salmonella
positive or negative.
Measurement of anti-Salmonella antibody responses by 
ELISA
Anti-Salmonella IgG and IgM responses were determined
by ELISA on pre-infection and post mortem serum
samples using plates coated with S. Gallinarum lysate
antigen as described previously for S. Pullorum and S.
Typhimurium [9,25].
T-cell proliferation assay
Single cell suspensions of splenocytes were prepared from
post mortem samples by passing splenic tissue through
Falcon cell strainers (Life Technologies, Paisley, UK) in
RPMI1640 containing 100 U/ml penicillin, 1 µg/ml strep-
tomycin and 5% bovine serum. The majority of erythro-
cytes were removed by centrifugation at 35 × g for 10
minutes. Cell proliferation to S. Gallinarum antigen was
determined by uptake of tritiated thymidine as described
previously [9].
Quantitative analysis of cytokine mRNA expression
Total RNA was isolated from RNAlater-protected samples
using RNeasy min kits (Qiagen, Crawley, UK) following
manufacturer's protocols. Levels of expression of the
cytokines IL-1β and IFN-γ were determined by real-time
reverse transcription-polymerase chain reaction (RT-PCR)
using the ABI Prism 7700 Sequence Detection System
(TaqMan®; PE Applied Biosystems, Warrington, UK) as
previously described [9,26-28]. Values for expression of
mRNA were corrected against the expression of 28S rRNA
as a 'housekeeping' gene.
Statistical analysis
Statistical analysis was performed either using Microsoft
Excel or Minitab for Windows. Comparison betweenPage 5 of 6
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of P < 0.05 were taken as significant.
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